

[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI
[ Fri, Aug 10th 2018
] - WOPRAI

[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
Matteis Paul Maintained (ACAD) at Hold with Decreased Target to $14 on, Aug 9th, 2018
Matteis Paul of Stifel, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Decreased Target from $17 to $14 on, Aug 9th, 2018.
Matteis, nor any peers, have made any analyst calls on ACAD in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30